SCHEMBL28899642

SCHEMBL28899642

CS(=O)(=O)NN(C(=N)N)C(=N)Nc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
TAS2R38 P59533 2/20 0.41
HSD17B10 Q99714 2/20 0.41
TP53 P04637 1/20 0.41
TYR P14679 1/20 0.41
TSHR P16473 1/20 0.41
KEAP1 Q14145 1/20 0.41
KDM4E B2RXH2 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
PTPN7 P35236 1/20 0.39
BCAT2 O15382 1/20 0.38
TMPRSS6 Q8IU80 2/20 0.37
NAPRT Q6XQN6 1/20 0.37
MAPT P10636 2/20 0.37
GAA P10253 2/20 0.37
GFER P55789 1/20 0.37
CA12 O43570 2/20 0.36
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
CA9 Q16790 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14868313 0.72 TAS2R38 (0.45) ALDH1A1TAS2R38HSD17B10TP53TYR
SCHEMBL28960082 0.71 ALDH1A1 (0.41) ALDH1A1TAS2R38HSD17B10TP53TYR
SCHEMBL28899747 0.68 KDM4E (0.44) ALDH1A1TAS2R38HSD17B10TP53TYR
Phenylurea SCHEMBL28218284 0.68 GAA (0.68) ALDH1A1TAS2R38HSD17B10TP53TYR
SCHEMBL1740828 0.67 ALDH1A1 (0.44) ALDH1A1TAS2R38HSD17B10TP53TYR
SCHEMBL2001630 0.67 TAS2R38 (0.46) ALDH1A1TAS2R38HSD17B10TP53TYR
Hydrochloric Acid SCHEMBL31696764 0.66 ALDH1A1 (0.42) ALDH1A1TAS2R38HSD17B10TP53TYR
SCHEMBL28899654 0.65 ALDH1A1 (0.38) ALDH1A1TAS2R38HSD17B10TP53TYR
SCHEMBL28899663 0.65 ALDH1A1 (0.38) ALDH1A1TAS2R38HSD17B10TP53TYR
SCHEMBL5344491 0.65 NR3C2 (0.42) ALDH1A1CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115414480-A Dianhydrogalactitol in combination with radiation for treatment of non-small cell lung cancer and glioblastoma multiforme 德玛医药 2022-12-02 CN disclosed